Shiqi Ling

Shiqi Ling

Auto-generated profile, based on publicly available information

Shiqi Ling

Department of Dermatology Dermatology Hospital, Southern Medical University Guangzhou China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
HSHuichun Su
Huichun Su
YLYang Luo
Yang Luo
JSJing Sun
Jing Sun
XLXiaochun Liu
Xiaochun Liu
SLShiqi Ling
Shiqi Ling
XYXu Yao
Xu Yao

8 May 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
SLShiqi Ling
Shiqi Ling
BXBeilei Xu
Beilei Xu
YLYang Luo
Yang Luo
XFXiaokai Fang
Xiaokai Fang
XLXiaochun Liu
Xiaochun Liu
XYXu Yao
Xu Yao

19 December 2023 in Cell Reports Medicine
Verified
Journal Article
Open access
XLXiaochun Liu
Xiaochun Liu
BXBeilei Xu
Beilei Xu
XXXiaoqiang Xu
Xiaoqiang Xu
ZWZhifeng Wang
Zhifeng Wang
YLYang Luo
Yang Luo
XYXu Yao
Xu Yao
Allergen-specific immunotherapy (AIT) has shown beneficial effects against atopic dermatitis (AD); however, the mechanisms and parameters underlying the efficacy of AIT remain unclear. Here, we report that the community structure and function of the oral and gut microbiota are changed in patients with AD undergoing AIT. Transplantation of fecal microbiota from patients who respond well to AIT improves AD-like dermatitis in mice. The abundance of Brevundimonas vesicularis in the gut of AD patients has been found to be positively correlated with disease severity and is decreased following AIT. Furthermore, we find that B. vesicularis from the oral cavity might ectopically colonize the gut of AD patients. In AD model mice, meanwhile, B. vesicularis promotes the skewing of the Treg/Th17 balance toward Th17 polarization and attenuates the efficacy of ovalbumin-specific immunotherapy. Our findings provide potential strategies for the optimization of AIT for AD via the modulation of the gut microbiota.

22 July 2026 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
SLShiqi Ling
Shiqi Ling
SJSuyun Ji
Suyun Ji
ZZZhe Zhuang
Zhe Zhuang
JGJinglin Gao
Jinglin Gao
YZYongjie Zeng
Yongjie Zeng
GZGuannan Zhu
Guannan Zhu